查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲經皮給藥系統市場預測至 2030 年 - 區域分析 - 按類型、應用和配銷通路
市場調查報告書
商品編碼
1510745

歐洲經皮給藥系統市場預測至 2030 年 - 區域分析 - 按類型、應用和配銷通路

Europe Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 120 Pages | 訂單完成後即時交付

價格

歐洲經皮給藥系統市場預計將從2022年的104.3386億美元成長到2030年的144.2286億美元。

對非侵入性給藥設備不斷成長的需求推動了歐洲經皮給藥系統市場

傳統的藥物傳遞技術，例如肌肉內、靜脈注射和直腸給藥，並不受到某些患者群體的青睞，主要是因為它們帶來的疼痛和複雜性。隨著醫學科學和明確的藥物傳輸技術的進步，非侵入性藥物傳輸系統現在將與傳統的注射給藥途徑競爭。非侵入性給藥系統包括口服給藥；專題；經皮主動（設備輔助增強滲透）和經皮被動；以及吸入藥物產生的經眼膜、經由黏膜及肺泡膜。經皮藥物遞送在許多方面都優於口服給藥途徑。特別是，它避開了肝臟的首過機制，否則肝臟會衝動地代謝藥物。

此外，經皮給藥不像皮下注射那麼痛苦，而且這種途徑不會產生危險的醫療廢物，也不會因針頭重複使用而造成疾病傳播的風險，這在發展中國家和低度開發國家尤其常見。此外，非侵入性經皮給藥系統簡化了給藥方案，並且可以自行給藥。當非侵入性給藥時，由於疼痛很少或沒有疼痛，患者的依從性要高得多。因此，該途徑被認為是優選的藥物遞送模式。此外，由於患者可自行給藥，非侵入性給藥系統可顯著降低臨床使用成本。因此，與經皮藥物遞送系統促進的非侵入性藥物遞送相關的優勢推動了市場的成長。

歐洲經皮給藥系統市場概況

歐洲經皮給藥系統市場分為英國、法國、德國、西班牙、義大利和歐洲其他地區。 2022年，德國在歐洲經皮給藥系統市場中佔最大佔有率。由於該地區對疼痛管理的需求不斷成長以及心血管疾病的盛行率不斷上升，預計該市場將大幅成長。心臟衰竭、心肌梗塞、冠狀動脈心臟病和發炎性心臟病等心血管疾病是該地區最廣泛的健康問題。德國以其先進的技術而聞名，這些技術幫助該國在醫療和保健領域處於領先地位。根據美國國家生物技術資訊中心 (NCBI) 2021 年發表的一項研究，東德的心血管疾病盛行率往往較高。近年來，該國也見證了市場參與者不斷增加的創新。 2023 年 5 月，BioNxt Solutions Inc. 獲得政府批准，對旨在治療帕金森氏症的經皮羅替高汀貼片進行藥物吸收比較研究。該公司在北美和歐洲設有研發業務，營運重點在德國，目前正在接受歐洲市場醫療產品的監管批准和商業化。

2019 年 3 月，LTS Lohmann Therapie-Systeme AG 和 LEO Pharma A/S 共同啟動了局部皮內治療牛皮癬的微陣列貼片的臨床試驗。

德國也是出口醫療保健產品和服務的主要國家之一。此外，技術進步資產也為品質、安全性和可靠性設定了國際標準。此外，所有健康和醫療領域的德國製造商和服務提供者透過提供醫療保健創新吸引了外國客戶和合作夥伴。經皮貼片的此類發展推動了德國經皮給藥系統市場的成長。

歐洲經皮給藥系統市場收入及 2030 年預測（百萬美元）

歐洲經皮給藥系統市場細分

歐洲經皮給藥系統市場按類型、應用、配銷通路和國家細分。

根據類型，歐洲經皮給藥系統市場分為經皮貼片、經皮凝膠、經皮噴霧等。 2022年，經皮凝膠細分市場將佔據歐洲經皮給藥系統市場的最大佔有率。劑。

從應用來看，歐洲經皮給藥系統市場分為心血管疾病、中樞神經系統疾病、疼痛管理、荷爾蒙應用和其他應用。到2022年，疼痛管理領域在歐洲經皮給藥系統市場中佔據最大佔有率。荷爾蒙應用進一步細分為經皮雌激素和黃體素治療以及睪固酮替代療法。

依配銷通路，歐洲經皮給藥系統市場分為醫院藥局、零售藥局、線上藥局等。 2022年，醫院藥局部門在歐洲經皮給藥系統市場中佔最大佔有率。

根據國家/地區，歐洲經皮給藥系統市場分為英國、法國、德國、西班牙、義大利和歐洲其他地區。 2022年，德國在歐洲經皮給藥系統市場佔據主導地位。

勃林格殷格翰國際有限公司、葛蘭素史克公司、久光製藥有限公司、強生公司、Lavipharm SA、綠葉製藥Group Limited、諾華公司、UCB SA 和Viatris Inc 是歐洲經皮給藥系統市場的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲經皮給藥系統市場 - 主要產業動態

  • 市場促進因素
    • 慢性病盛行率增加
    • 對非侵入性給藥設備的需求不斷成長
    • 自我用藥需求旺盛
  • 市場限制
    • 經皮給藥系統的不良反應與召回
  • 市場機會
    • 智慧補丁和 3D 列印補丁的進步
  • 未來的趨勢
    • 製造商的策略舉措
  • 影響分析

第 5 章：經皮給藥系統市場 - 歐洲市場分析

  • 歐洲經皮給藥系統市場收入，2022 - 2030

第 6 章：歐洲經皮給藥系統市場 - 收入和 2030 年預測 - 按類型

  • 概述
  • 歐洲經皮給藥系統市場收入佔有率，按類型 2022 年和 2030 年 (%)
  • 經皮貼劑
  • 經皮凝膠
  • 經皮噴劑
  • 其他

第 7 章：歐洲經皮給藥系統市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年及 2030 年歐洲經皮給藥系統市場收入佔有率，依應用分類 (%)
  • 心血管疾病
  • 中樞神經系統疾病
  • 疼痛管理
  • 荷爾蒙應用
  • 其他應用

第 8 章：歐洲經皮給藥系統市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年及 2030 年歐洲經皮給藥系統市場收入佔有率，依配銷通路分類 (%)
  • 醫院藥房
  • 零售藥局
  • 網路藥局
  • 其他

第 9 章：歐洲經皮給藥系統市場 - 收入與 2030 年預測 - 國家分析

  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第 10 章：經皮給藥系統市場產業格局

  • 概述
  • 經皮給藥系統市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • UCB SA

第 12 章：附錄

Product Code: TIPRE00013279

The Europe transdermal drug delivery system market is expected to grow from US$ 10,433.86 million in 2022 to US$ 14,422.86 million by 2030. It is estimated to register a CAGR of 4.1% from 2022 to 2030.

Growing Demand for Noninvasive Drug Delivery Devices Fuels Europe Transdermal Drug Delivery System Market

Traditional drug delivery techniques such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations mainly due to the pain and complexities associated with them. With the improvements in medical science and definite drug delivery technologies, noninvasive drug delivery systems are now set to compete with the traditional method of injectable route of drug administration. The noninvasive drug delivery systems include drug delivery via oral; topical; transdermal-active (device-aided enhanced penetration) and transdermal-passive; and transocular membrane, transmucosal membrane, and alveolar membrane from inhaled medication. Transdermal drug delivery is advantageous in many ways over the oral route of administration. In particular, it evades the first-pass mechanism of the liver, which can otherwise impulsively metabolize drugs.

Further, transdermal delivery is not as painful as hypodermic injections, and this route leads to no dangerous medical waste and poses no risk of disease transmission by needle reuse, which is especially common in developing and under-developed countries. In addition, a noninvasive transdermal drug delivery system has simplified dosing schedules, and the drugs can be self-administered. Patient compliance is much higher when drugs are administrated noninvasively due to low or no pain involved. Therefore, this route is considered a preferred mode of drug delivery. Moreover, a non-invasive drug delivery system can significantly reduce the cost of clinical use because of the self-administration of the drugs by the patients. Thus, the advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems drive the market growth.

Europe Transdermal Drug Delivery System Market Overview

The Europe transdermal drug delivery system market is segmented into the UK, France, Germany, Spain, Italy, and the Rest of Europe. In 2022, the Germany held the largest share of the Europe transdermal drug delivery system market. The market is expected to grow significantly owing to the growing need for pain management and the increasing prevalence of cardiovascular diseases in the region. Cardiovascular diseases such as heart failure, myocardial infarction, coronary cardiac disease, and inflammatory heart disease account for the broadest health problems in the region. Germany is known for its advancement in technology that helps lead the country to the forefront in the medical and healthcare sectors. According to a study published in 2021 in the National Center for Biotechnology Information (NCBI), cardiovascular disease prevalence is often higher in East Germany. The country has also witnessed increasing innovations through market players in recent years. In May 2023, BioNxt Solutions Inc. received government approval to proceed with a comparative drug absorption study for a transdermal Rotigotine patch designed to treat Parkinson's disease. The company has R&D operations in North America and Europe, with an operational focus in Germany, and is currently undergoing regulatory approval and commercialization of medical products for European markets.

In March 2019, LTS Lohmann Therapie-Systeme AG and LEO Pharma A/S together started a clinical trial of microarray patches for the local intradermal treatment of psoriasis.

Germany is also among the primary countries that export healthcare products and services. In addition, the asset of technological advancement has set international standards for quality, safety, and reliability. Moreover, the German manufacturers and service providers in all health and medical segments fascinate foreign customers and partners by delivering healthcare innovation. Such developments in transdermal patches fuel the growth of the transdermal drug delivery system market in Germany.

Europe Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Europe Transdermal Drug Delivery System Market Segmentation

The Europe transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Europe transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Europe transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Europe transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Europe transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Europe transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Europe transdermal drug delivery system market in 2022.

Based on country, the Europe transdermal drug delivery system market is categorized into the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany dominated the Europe transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Lavipharm SA, Luye Pharma Group Ltd, Novartis AG, UCB SA, and Viatris Inc are some of the leading companies operating in the Europe transdermal drug delivery system market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic Diseases
    • 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 4.1.3 High Demand for Self-Administration of Drugs
  • 4.2 Market Restraints
    • 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 4.4 Future Trends
    • 4.4.1 Strategic Initiatives by Manufacturers
  • 4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Europe Market Analysis

  • 5.1 Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Transdermal Patches
    • 6.3.1 Overview
    • 6.3.2 Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Drug-in-Adhesive Patches
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Matrix Patches
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Reservoir Membrane Patches
        • 6.3.2.3.1 Overview
        • 6.3.2.3.2 Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.4 Vapor Patches
        • 6.3.2.4.1 Overview
        • 6.3.2.4.2 Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Transdermal Gels
    • 6.4.1 Overview
    • 6.4.2 Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Transdermal Sprays
    • 6.5.1 Overview
    • 6.5.2 Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Overview
    • 7.3.2 Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Central Nervous System Disorders
    • 7.4.1 Overview
    • 7.4.2 Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Pain Management
    • 7.5.1 Overview
    • 7.5.2 Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 Opioid
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.2 Non-Opioid
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Hormonal Applications
    • 7.6.1 Overview
    • 7.6.2 Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 Testosterone Replacement
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Application
    • 7.7.1 Overview
    • 7.7.2 Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

  • 9.1 Europe Transdermal Drug Delivery System Market
    • 9.1.1 Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 9.1.1.1 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.3 Germany: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3.1 Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 Germany: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.1 Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.2 Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.5 Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.3 France: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3.1 France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 France: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.1 France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.2 France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.5 France: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.3 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.3 UK: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.3.1 UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 UK: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.1 UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.2 UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.5 UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.4 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.3 Italy: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.3.1 Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Italy: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.1 Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.2 Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.5 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.3 Spain: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.3.1 Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 Spain: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.1 Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.2 Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.5 Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.3.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.2 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Novartis AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 GSK Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Viatris Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Boehringer Ingelheim International GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Hisamitsu Pharmaceutical Co Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Luye Pharma Group Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Lavipharm SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 UCB SA
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Transdermal Drug Delivery System Market Segmentation
  • Table 2. Germany: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. UK: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. UK: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 40. Glossary of Terms, Europe Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Europe Transdermal Drug Delivery System Market Segmentation, By Country
  • Figure 2. Europe Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 3. Europe Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 25. Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 31. Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market